J. Larham

COVID symptoms, testing, shielding impact on patient‐reported outcomes and early vaccine responses in individuals with multiple myeloma

M. Drayson, R. Sadler, K. Ramasamy, 2021, British journal of haematology.

COVID symptoms, testing, shielding impact on patient‐reported outcomes and early vaccine responses in individuals with multiple myeloma

M. Drayson, R. Sadler, K. Ramasamy, 2021, medRxiv.

Myeloma clinical outcomes following the first wave of COVID‐19: results from the Thames Valley Cancer Alliance (UK)

K. Ramasamy, J. Larham, S. Gooding, 2020, British journal of haematology.

Immune response to COVID‐19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T‐cell response

N. Gray, M. Drayson, R. Sadler, 2021, medRxiv.